249 related articles for article (PubMed ID: 25877159)
1. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
Tokue A; Higuchi T; Arisaka Y; Nakajima T; Tokue H; Tsushima Y
Ann Nucl Med; 2015 Jul; 29(6):499-505. PubMed ID: 25877159
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437
[TBL] [Abstract][Full Text] [Related]
3. Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Lee J; Hyun SH; Kim S; Kim DK; Lee JK; Moon SH; Cho YS; Choe YS; Kim BT; Lee KH
Clin Nucl Med; 2016 May; 41(5):e237-43. PubMed ID: 26914555
[TBL] [Abstract][Full Text] [Related]
4. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.
Zhang J; Chen H; Ma Y; Xiao Y; Niu N; Lin W; Wang X; Liang Z; Zhang F; Li F; Zhang W; Zhu Z
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1624-34. PubMed ID: 24764034
[TBL] [Abstract][Full Text] [Related]
5. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
6. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of
Bai Z; Zhou T; Yu Z; Chen Y; Dong L
Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
[TBL] [Abstract][Full Text] [Related]
8. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
12. Abnormal [
Nagahata K; Kanda M; Kamekura R; Sugawara M; Yama N; Suzuki C; Takano K; Hatakenaka M; Takahashi H
Ann Nucl Med; 2022 Feb; 36(2):200-207. PubMed ID: 34748155
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
14. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.
Shimizu M; Okamura K; Kise Y; Takeshita Y; Furuhashi H; Weerawanich W; Moriyama M; Ohyama Y; Furukawa S; Nakamura S; Yoshiura K
Arthritis Res Ther; 2015 Aug; 17(1):223. PubMed ID: 26298875
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
18. Total lesion glycolysis as an IgG4-related disease activity marker.
Nakatsuka Y; Handa T; Nakamoto Y; Nobashi T; Yoshihuji H; Tanizawa K; Ikezoe K; Sokai A; Kubo T; Hirai T; Chin K; Togashi K; Mimori T; Mishima M
Mod Rheumatol; 2015 Jul; 25(4):579-84. PubMed ID: 25437196
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
